We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Humacyte

News List

Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp. firstwordpharma
August 27, 2021
Humacyte, Inc. today announced the successful completion of its business combination (the "Business Combination") with Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination firstwordpharma
August 05, 2021
Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) ("AHAC"), a special purpose acquisition company, today announced that it has filed a definitive proxy statement with the Securities and Exchange Commission ("SEC") and set a date of August 24, 2021.
Humacyte agrees SPAC merger to go public with bioengineered tissue tech pharmaceutical-technology
February 23, 2021
Human tissue bioengineering biotech Humacyte has entered into a business combination agreement with special purpose acquisition company (SPAC) Alpha Healthcare Acquisition Corp (AHAC).